Rupert D’Souza's most recent trade in Adverum Biotechnologies Inc was a trade of 10,000 Common Stock done at an average price of $0.8 . Disclosure was reported to the exchange on May 13, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Adverum Biotechnologies Inc | Rupert D’Souza | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.83 per share. | 13 May 2022 | 10,000 | 20,850 (0%) | 0% | 0.8 | 8,272 | Common Stock |
Adverum Biotechnologies Inc | Rupert D’Souza | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.86 per share. | 13 May 2022 | 10,000 | 10,850 (0%) | 0% | 0.9 | 8,585 | Common Stock |
Adverum Biotechnologies Inc | Rupert D’Souza | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2021 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) |